# ARQT: Arcutis Biotherapeutics, Inc. Common Stock

- Industry: Pharmaceutical Preparations
- Current price: $25.38
- Price updated: Sep 19, 2026
- Total congressional trades: 1
- Politicians trading: 1
- Last traded: Dec 11, 2025
- Source: https://tryglasshouse.ai/companies/ARQT.md

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

# Congressional trading history

- Page: 1 of 1
- Results: 1 of 1
- Pagination query parameter: `page`

## 1. Gilbert Ray Cisneros, Jr.

- Member: Democrat, House
- Transaction: Sell, $1,001 - $15,000
- Dates: traded Dec 11, 2025, disclosed Jan 12, 2026
- Market context: $29.47 at trade, $25.38 current (-13.88%)
- Politician: https://tryglasshouse.ai/politicians/C001123.md
- Record: https://tryglasshouse.ai/trades/280be608-0586-47ff-8bab-782d8cb40e4b.md



Prices and percentage changes are market context, not portfolio returns. This information is not financial advice.